MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    MR-morphological changes in PD patients with heterozygous GBA mutation

    J. Reimer, K. Faust, GH. Schneider, AA. Kühn, P. Krause (Berlin, Germany)

    Objective: This study investigates possible cerebral morphological differences between GBA-gene-mutation carriers with Parkinson´s disease (PD) and PD-patients without GBA-gene-mutation depending on in- or exclusion of…
  • 2023 International Congress

    Parkinson’s disease and Charcot-Marie-Tooth type 2: coincidental or causal?

    G. Prado-Miranda, S. Bansal, S. Sharma, M. Jog (London, Canada)

    Objective: To report a patient with Charcot-Marie-Tooth (CMT) type 2N (CMT2N) due to AARS gene mutation who developed early-onset Parkinson’s disease (PD). Background: Aminoacyl tRNA…
  • 2023 International Congress

    Optimal topographic characteristics of focused ultrasound unilateral thalamotomy for tremor-dominant Parkinson´s disease

    E. Natera-Villalba, JA. Pineda-Pardo, M. Del álamo, M. Matarazzo, R. Rodríguez-Rojas, R. Raimundo, R. Martínez-Fernández, JA. Obeso (Madrid, Spain)

    Objective: To define topography that correlates with tremor control after unilateral focused ultrasound (FUS) thalamotomy for tremor-dominant Parkinson´s Disease (TDPD). Background: Unilateral FUS thalamotomy of…
  • 2023 International Congress

    Parkinson’s disease management in the community

    L. Ambrosio, MV. Navarta, D. Kunkel, A. Pedraz-Marcos, A. Palmar-Santos, A. Haahr, LB. Vester, LK. Bragstad, TL. Nielsen, NB. Kruse, EG. Hjelle, SB. Haavaag, MC. Portillo (Southampton, United Kingdom)

    Objective: To explore perceptions of people with Parkinson's disease and family carers about the use and impact of health and social care services, community and…
  • 2023 International Congress

    Exome-wide contribution of ultra-rare variants to the genetic architecture of Parkinson’s disease and Cutaneous Malignant Melanoma

    B. Bustos, T. Krainc, Z. Gan-Or, C. Cruchaga, B. Benitez, T. Bishop, H. Morris, S. Lubbe (Chicago, USA)

    Objective: To analyze the UKBiobank cohorts of Parkinson’s disease (PD) and Cutaneous Malignant Melanoma to uncover shared genetic factors explained by ultra-rare damaging coding variants…
  • 2023 International Congress

    A pilot, randomized, placebo controlled, double-blinded, delayed start trial of Modafinil for the treatment of Freezing of Gait in Parkinson’s disease.

    T. Virmani, L. Pillai, R. Landes, A. Glover, M. Lotia, R. Dhall, E. Garcia-Rill (LITTLE ROCK, USA)

    Objective: To determine if modafinil could improve gait and freezing in people with Parkinson’s disease (PwPD)with freezing of gait (FOG). Background: FOG is a debilitating…
  • 2023 International Congress

    Application of multi-parametric diffusion MRI in detecting visual disturbances in advanced Parkinson’s disease population

    K. Shivok, I. Ailes, M. Syed, I. Shelley, A. Alhussein, I. Fayed, T-W. Liang, C. Wu, A. Sharan, F. Mohamed, R. Sergott, L. Krisa, M. Alizadeh (Philadelphia, USA)

    Objective: We aimed to identify differences in multi-parametric diffusion indices (DTI, NODDI, and DKI) between Parkinson’s disease patients with visual disturbances and those without. Background:…
  • 2023 International Congress

    Longitudinal clinical and biomarker characteristics of non-manifest GBA1 N409S carriers: the PPMI cohort

    P. Gonzalez-Latapi, D. Harvell, T. Simuni, K. Merchant, M. Brumm, R. Alcalay, H. Cho, C. Caspell-Garcia, C. Gochanour, C. Coffey, K. Marek (Chicago, USA)

    Objective: To examine longitudinal change in clinical characteristics, dopamine transporter (DAT) imaging and biofluid biomarkers in GBA1 N409S non-manifesting carriers (NMCs) versus healthy controls (HCs)…
  • 2023 International Congress

    Clinal comprehensive Next-gen gene panel for Parkinson’s Disease

    Z. Niu, E. Lauer, S. Roellinger, L. Hasadsri, O. Ross, R. Savica (Rochester, USA)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people. There is growing evidence on both gene mutations associated with PD and…
  • 2023 International Congress

    Gender differences in non-motor fluctuations in Parkinson’s disease

    G. Donzuso, C. Cicero, E. Vinciguerra, R. Sergi, A. Luca, G. Mostile, C. Terravecchia, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To estimate the burden of NMF in PD patients and to evaluate the possible gender effect. Background: Non-motor symptoms (NMS) are commonly experienced by…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley